We're increasing our Eli Lilly price target after another beat-and-raise quarter

The strength of its GLP-1 business suggests the stock still has more room to run.
Trade News wire, 2026-08-05: We're increasing our Eli Lilly price target after another beat-and-raise quarter The strength of its GLP-1 business suggests the stock still has more room to… Primary source: original at CNBC Finance (cnbc.com).
We're increasing our Eli Lilly price target after another beat-and-raise quarter

The strength of its GLP-1 business suggests the stock still has more room to run.